Which patient factors increase the risk of fluoroquinolone-associated reactions?

Warunek, Letitia N; Smith, Susan M

Warunek, Letitia N; Smith, Susan M.

Afiliación

Warunek LN; Letitia N. Warunek is an assistant professor of pharmacy practice and clinical pharmacist in internal medicine at Wilkes University Nesbitt School of Pharmacy in Wilkes-Barre, Pa. Susan M. Smith is an assistant professor of pharmacy and clinical pharmacist in internal medicine at Wingate (N.C.) University School of Pharmacy. The authors have disclosed no potential conflicts of interest, financial or otherwise.

JAAPA ; 36(2): 15-16, 2023 Feb 01.

Article en En | MEDLINE | ID: mdl-36701574

ABSTRACT

ABSTRACT

ABSTRACT Fluoroquinolones commonly are used to treat a variety of infections in the urinary, gastrointestinal, and respiratory tracts. Clinicians should evaluate patients to ensure that a fluoroquinolone is a safe and effective therapy to treat the infection. This article discusses patient factors that increase the risk for serious adverse drug reactions that can occur with fluoroquinolone use.

Asunto(s)

Antibacterianos; Fluoroquinolonas; Humanos; Fluoroquinolonas/efectos adversos; Antibacterianos/efectos adversos; Factores de Riesgo

Texto completo

Imprimir

XML

PubMed Links

Buscar en Google

Texto completo: 1 Colección: 01-internacional Banco de datos: MEDLINE Asunto principal: Fluoroquinolonas / Antibacterianos Tipo de estudio: Etiology_studies / Risk_factors_studies Límite: Humans Idioma: En Revista: JAAPA Asunto de la revista: MEDICINA Año: 2023 Tipo del documento: Article

Texto completo

Imprimir

XML

PubMed Links

Buscar en Google